A5098946947- Diabetes Treatment and Management
- Glaucoma and retinal disorders
- Thyroid Disorders and Treatments
- Metabolism, Diabetes, and Cancer
- Pharmacology and Obesity Treatment
- Diet and metabolism studies
- Ophthalmology and Eye Disorders
- Liver Disease Diagnosis and Treatment
Hochschule Düsseldorf University of Applied Sciences
2024
Deutsches Diabetes-Zentrum e.V.
2024
Heinrich Heine University Düsseldorf
2024
German Center for Diabetes Research
2024
Summary Background The current obesity pandemic has given rise to associated comorbidities and complications, including type 2 diabetes metabolic dysfunction‐associated steatotic liver disease (MASLD). During the last decade, certain glucagon‐like peptide 1 receptor agonists (GLP‐1RA), originally developed as antihyperglycemic drugs, also demonstrated efficacy for weight loss. Aims To review shared pathophysiologic features of common diseases compare therapeutic strategies reduce body...
Hyperglycemia in type 2 diabetes (T2D) associates with higher glucagon secretion, which may be further promoted the presence of metabolic dysfunction-associated steatotic liver disease (MASLD). Thus, we compared fasting and prandial glucagonemia people without recent-onset T2D MASLD. Participants German Diabetes Study (GDS), (n=50; known duration <1 year) or normal glucose tolerance (NGT; n=50), underwent mixed meal tests (MMT; 365 kcal) hyperinsulinemic-normoglycemic clamps. Early...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)